Results 151 to 160 of about 69,036 (281)
Factors Associated with Early Discontinuation of Foslevodopa/Foscarbidopa in Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.
Keita Kakuda +7 more
wiley +1 more source
Abstract Background Most fall‐prediction models in Parkinson's disease (PD) rely on prior falls, limiting prevention. The Waiting Room of the Future (WROTF) platform collects standardized motor and cognitive measures during routine visits, integrated into electronic health records (EHR).
Saar Anis +5 more
wiley +1 more source
Levodopa: A novel therapeutic prospect for liver disease. [PDF]
Xu J, Qian Y, Wang JM, Wu XL, Zheng YY.
europepmc +1 more source
Abstract Objective Investigate the efficacy of immediate‐release (IR) amantadine in reducing the risk of peak‐dose dyskinesia in early Parkinson's disease (PD) as add‐on to levodopa. Background While the use of amantadine to manage dyskinesia in PD is well supported by controlled clinical trials, data on its efficacy in patients without motor ...
Olivier Rascol +106 more
wiley +1 more source
Abstract Background The effect of deep brain stimulation (DBS) on gait in patients with Parkinson's disease (PD) remains variable, and prospective, long‐term studies, especially involving globus pallidus interna (GPi) stimulation, are limited. Objectives We tested the hypothesis that subthalamic nucleus (STN) and GPi DBS exert acute and chronic effects
Jamal Al Ali +14 more
wiley +1 more source
Subcutaneous Levodopa in Parkinson's Disease: A Systematic Review and Meta-Analysis. [PDF]
Burton M +6 more
europepmc +1 more source
Diurnal‐Only Foslevodopa/Foscarbidopa
Movement Disorders Clinical Practice, EarlyView.
Alexandra McGuckin +3 more
wiley +1 more source
Early improvement of dystonia after globus pallidus internus‐deep brain stimulation (GPi‐DBS) is associated with stimulation of the globus pallidus externus‐subthalamic nucleus (GPe‐STN) fibers and the lenticular fasciculus. Functional connectivity to the cerebellar cortex and the limbic and default mode networks predict early improvement of symptoms ...
A. Enrique Martinez‐Nunez +9 more
wiley +1 more source
The effect of levodopa on speech graphs in non-demented patients with multiple system atrophy and Parkinson's disease. [PDF]
Liu J, Zhao Y, Ma J, Zhang G.
europepmc +1 more source
Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's Disease
Abstract Focused ultrasound is rapidly emerging as a novel technology for the development of symptomatic therapies and supporting disease‐modifying treatments for Parkinson's disease (PD). At the forefront of this development is thermoablation using high‐intensity focused ultrasound, an incisionless treatment that has been extensively tested in ...
Rikke Hahn Kofoed +7 more
wiley +1 more source

